2-(4-Fluorophenyl)-4,6-diphenyl-1,3,5-triazine

Catalog No. :
ACXSBN798
CAS No. :
203450-08-2
Molecular Formula :
C21H14FN3
Molecular Weight :
327.36

IUPAC Name:2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine

2-(4-Fluorophenyl)-4,6-diphenyl-1,3,5-triazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g97%$53.00Login to see priceIn stockInquiry
25g97%$118.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Fluorophenyl)-4,6-diphenyl-1,3,5-triazine
IUPAC Name2-(4-fluorophenyl)-4,6-diphenyl-1,3,5-triazine
MDL No.MFCD28964710
Molecular FormulaC21H14FN3
Molecular Weight327.36
SMILESFC1=CC=C(C2=NC(C3=CC=CC=C3)=NC(C4=CC=CC=C4)=N2)C=C1
InChI KeyDEFTZOFCLNDIMR-UHFFFAOYSA-N
SynonymDTXSID501245804 | MFCD28964710 | C21H14FN3 | CS-0156380 | 1,3,5-Triazine, 2-(4-fluorophenyl)-4,6-diphenyl- | AMY37851 | AKOS026673983 | DS-9928 | F1045 | C73839 | 2-(4-Fluorophenyl)-4,6-diphenyl-1,3,5-triazine | FT-0750066 | SB73708 | SCHEMBL18689509 | SY
CAS No.203450-08-2
PubChem CID15850059

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACXSBN798 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRALY215 route compound structure diagram
    ACRALY2153842-55-5 In Stock
  2. Plus
  3. ACUXPT746 route compound structure diagram
    ACUXPT7461765-93-1 In Stock
  4. Then
  5. ACXSBN798 route product structure diagram
    ACXSBN798203450-08-2 In Stock
Inquiry

2. ACXSBN798 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACXSBN798 route product structure diagram
    ACXSBN798203450-08-2 In Stock
Inquiry

Comments (0)